- Stocks
- Healthcare
- NASDAQ: OMIC

Price (delayed)

$13.01

Market cap

$32.47M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$37.37

Enterprise value

$73.54M

OMIC's revenue is up by 28% year-on-year and by 9% since the previous quarter

OMIC's EPS is up by 5% since the previous quarter and by 5% year-on-year

Singular Genomics Systems's debt has increased by 23% YoY but it has decreased by 2.4% QoQ

OMIC's quick ratio is down by 47% year-on-year and by 16% since the previous quarter

Singular Genomics Systems's equity has decreased by 37% YoY and by 12% QoQ

What are the main financial stats of OMIC

Market
Valuations
Earnings

Shares outstanding

2.5M

Market cap

$32.47M

Enterprise value

$73.54M

Price to earnings (P/E)

N/A

Price to book (P/B)

0.23

Price to sales (P/S)

11.86

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

27.02

Revenue

$2.72M

EBIT

-$90.75M

EBITDA

-$83.72M

Free cash flow

-$77.98M

Per share
Balance sheet
Liquidity

EPS

-$37.37

Free cash flow per share

-$31.44

Book value per share

$55.76

Revenue per share

$1.1

TBVPS

$88.69

Total assets

$220M

Total liabilities

$82.3M

Debt

$71.79M

Equity

$137.71M

Working capital

$131.75M

Debt to equity

0.52

Current ratio

8.77

Quick ratio

7.92

Net debt/EBITDA

-0.49

Margins
Efficiency
Dividend

EBITDA margin

-3,075.6%

Gross margin

-41.1%

Net margin

-3,375.7%

Operating margin

-3,654.4%

Return on assets

-36.4%

Return on equity

-54.7%

Return on invested capital

-32%

Return on capital employed

-44.7%

Return on sales

-3,333.8%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the Singular Genomics Systems stock price performed over time

Intraday

5.09%

1 week

116.47%

1 month

95.93%

1 year

3.5%

YTD

-5.72%

QTD

53.96%

How have Singular Genomics Systems's revenue and profit performed over time

Revenue

$2.72M

Gross profit

-$1.12M

Operating income

-$99.47M

Net income

-$91.89M

Gross margin

-41.1%

Net margin

-3,375.7%

OMIC's revenue is up by 28% year-on-year and by 9% since the previous quarter

Singular Genomics Systems's net margin has increased by 23% YoY and by 13% QoQ

OMIC's operating margin is up by 22% year-on-year and by 13% since the previous quarter

The gross profit has declined by 8% since the previous quarter

What is Singular Genomics Systems's growth rate over time

What is Singular Genomics Systems stock price valuation

P/E

N/A

P/B

0.23

P/S

11.86

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

27.02

OMIC's EPS is up by 5% since the previous quarter and by 5% year-on-year

Singular Genomics Systems's equity has decreased by 37% YoY and by 12% QoQ

The P/B is 10% above the last 4 quarters average of 0.2

OMIC's revenue is up by 28% year-on-year and by 9% since the previous quarter

How efficient is Singular Genomics Systems business performance

The ROE has contracted by 45% YoY and by 7% from the previous quarter

OMIC's ROS is up by 24% year-on-year and by 13% since the previous quarter

The ROA has contracted by 22% YoY

The return on invested capital is up by 9% year-on-year and by 4.2% since the previous quarter

What is OMIC's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for OMIC.

How did Singular Genomics Systems financials performed over time

Singular Genomics Systems's total assets is 167% higher than its total liabilities

OMIC's quick ratio is down by 47% year-on-year and by 16% since the previous quarter

The company's current ratio fell by 46% YoY and by 15% QoQ

Singular Genomics Systems's debt is 48% lower than its equity

The company's debt to equity has surged by 93% YoY and by 11% QoQ

Singular Genomics Systems's equity has decreased by 37% YoY and by 12% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.